Genetic aspects of primary hyperoxaluria: diagnostics and treatment


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Primary hyperoxaluria is a group of inherited metabolic diseases characterized by increased formation of calcium-oxalate stones in kidneys with development of nephrolithiasis and chronic kidney disease. The article summarizes the modern information on the diagnostics and treatment of the disorder depending on genotype of the patient (AGXT, GRHPR, HOGA1 genes). The evaluation of the molecular genetic aetiology of the kidney stone disease contributes to the personalized treatment and prevention of the pathology in the patients and their relatives.

Texto integral

Acesso é fechado

Sobre autores

T. Filippova

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University)

Email: dr.filippova@mail.ru

D. Svetlichnaya

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University); Moscow Regional Research and Clinical Institute

Email: div.swet@gmail.com

V. Rudenko

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University)

Email: rudenko-vadim@rambler.ru

Y. Alyaev

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University)

Email: ugalyaev@mail.ru

M. Shumikhina

N.F. Filatov Children’s City Hospital of Moscow Healthcare Ministry

Email: marina.shumikhina@gmail.com

M. Azova

Peoples’ Friendship University of Russia

Email: azovam@mail.ru

T. Subbotina

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University)

Email: subbotina@1msmu.ru

Z. Gadzhieva

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University)

Email: zgadzhieva@ooorou.ru

A. Asanov

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University)

Email: aliy@rambler.ru

M. Litvinova

I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University); The Loginov Moscow Clinical Scientific Center of Moscow Health Department

Email: ariya.litvinova@gmail.com

Bibliografia

  1. Kurt-Sukur E.D., Ozgakar Z.B., Fitoz S., Yilmaz S., Hoppe B., Yalginkaya F. Primary Hyperoxaluria Type 1: A Cause for Infantile Renal Failure and Massive Nephrocalcinosis. Klin. Padiatr. 2015; 227(5): 293-295.
  2. Campfield T., Braden G., Flynnvalone P., Powell S. Effect of diuretics on urinary oxalate, calcium, and sodium excretion in very low birth weight infants. Pediatrics 1997;99(6):814-818.
  3. Чугунова О.Л., Шумихина М.В., Павлушкина Л.В. Основные факторы риска развития мочекаменной болезни у детей. Педиатрия. 2018;97(5):93-103
  4. Ben-Shalom E., Frishberg Y. Primary hyperoxalurias: diagnosis and treatment. Pediatr. Nephrol. 2015;30(10):1781-1791.
  5. Lorenzo V., Torres A., Salido E. Hiperoxaluria primaria. Nefrologia 2014;34(3):398-412.
  6. Sas D.J., Harris P.C., Milliner D.S. Recent advances in the identification and management of inherited hyperoxalurias. Urolithiasis. 2019;47(1): 79-89.
  7. Greed L., Willis F., Johnstone L. et al. Metabolite diagnosis of primary hyperoxaluria type 3. Pediatr. Nephrol. 2018;33(8):1443-1446.
  8. Primary hyperoxaluria mutation database [Электронный ресурс]. Режим доступа: http://www.uclh.nhs.uk/OurServices/ServiceA-Z/ PATH/PATHBIOMED/CBIO/Pages/Phmdatabase.aspx (02.06.2019).
  9. Canales B.K., Hatch M. Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria. Surg. Obes. Relat. Dis. 2017;13(7):1152-1157.
  10. Aryans D., Jung Y.-C., Antonopoulos D. et al. Oxalobacter formigenes - Derived Bioactive Factors Stimulate Oxalate Transport by Intestinal Epithelial Cells. J. Am. Soc. Nephrol. 2017;28(3):876-887.
  11. Milliner D., Hoppe B., Groothoff J. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Urolithiasis. 2018;46(4): 313-323.
  12. Hulton S.A. The primary hyperoxalurias: A practical approach to diagnosis and treatment. Int. J. Surg. 2016;36(PD):649-654.
  13. Büscher R., Büscher A.K., Cetiner M. et al. Combined liver and kidney transplantation and kidney after liver transplantation in children: Indication, postoperative outcome, and long-term results. Pediatr. Transplant. 2015;19(8):858-865

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2019

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies